Cryosite Limited (ASX:CTE)
Australia · Delayed Price · Currency is AUD 1.000
0.00 (0.00%)
May 11, 2026, 11:06 AM AEST
Cryosite Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 15.75 | 14.12 | 12.61 | 11.94 | 11.76 | 10.02 |
| 15.75 | 14.12 | 12.61 | 11.94 | 11.76 | 10.02 | |
Revenue Growth (YoY) | 22.56% | 11.92% | 5.67% | 1.51% | 17.29% | 12.38% |
Cost of Revenue | 6.02 | 5.23 | 4.62 | 4.76 | 4.92 | 4.13 |
Gross Profit | 9.73 | 8.89 | 7.99 | 7.17 | 6.84 | 5.89 |
Selling, General & Admin | 5.87 | 5.52 | 5.15 | 4.95 | 4.39 | 4.09 |
Operating Expenses | 6.76 | 6.39 | 5.94 | 5.65 | 4.96 | 4.68 |
Operating Income | 2.97 | 2.5 | 2.05 | 1.52 | 1.88 | 1.21 |
Interest Expense | -0.18 | -0.15 | -0.16 | -0.07 | -0.08 | -0.11 |
Interest & Investment Income | 0.15 | 0.18 | 0.2 | 0.12 | 0.01 | 0.01 |
Currency Exchange Gain (Loss) | - | - | - | - | - | -0.04 |
Other Non Operating Income (Expenses) | - | - | - | - | - | 0.05 |
EBT Excluding Unusual Items | 2.95 | 2.52 | 2.09 | 1.58 | 1.81 | 1.12 |
Pretax Income | 2.95 | 2.52 | 2.09 | 1.58 | 1.81 | 1.12 |
Income Tax Expense | 0.76 | 0.64 | 0.25 | 0.17 | 0.44 | 0.47 |
Earnings From Continuing Operations | 2.18 | 1.88 | 1.84 | 1.41 | 1.36 | 0.65 |
Net Income | 2.18 | 1.88 | 1.84 | 1.41 | 1.36 | 0.65 |
Net Income to Common | 2.18 | 1.88 | 1.84 | 1.41 | 1.36 | 0.65 |
Net Income Growth | 19.21% | 2.39% | 30.59% | 3.30% | 109.02% | -55.91% |
Shares Outstanding (Basic) | 49 | 49 | 49 | 49 | 49 | 47 |
Shares Outstanding (Diluted) | 51 | 50 | 49 | 49 | 49 | 49 |
Shares Change (YoY) | 4.10% | 2.05% | - | - | - | - |
EPS (Basic) | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.01 |
EPS (Diluted) | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.01 |
EPS Growth | 14.39% | 0.27% | 30.59% | 3.47% | 108.22% | -55.78% |
Free Cash Flow | -1.78 | 1.48 | 2.27 | 1.11 | 1.66 | 0.12 |
Free Cash Flow Per Share | -0.04 | 0.03 | 0.05 | 0.02 | 0.03 | 0.00 |
Dividend Per Share | - | - | 0.020 | 0.015 | 0.010 | - |
Dividend Growth | - | - | 33.33% | 50.00% | - | - |
Gross Margin | 61.76% | 62.98% | 63.38% | 60.11% | 58.16% | 58.80% |
Operating Margin | 18.84% | 17.68% | 16.29% | 12.77% | 16.00% | 12.08% |
Profit Margin | 13.87% | 13.35% | 14.59% | 11.81% | 11.60% | 6.51% |
Free Cash Flow Margin | -11.33% | 10.47% | 17.97% | 9.28% | 14.13% | 1.18% |
EBITDA | 3.44 | 3.03 | 2.53 | 1.95 | 2.18 | 1.54 |
EBITDA Margin | 21.86% | 21.46% | 20.07% | 16.30% | 18.56% | 15.37% |
D&A For EBITDA | 0.48 | 0.53 | 0.48 | 0.42 | 0.3 | 0.33 |
EBIT | 2.97 | 2.5 | 2.05 | 1.52 | 1.88 | 1.21 |
EBIT Margin | 18.84% | 17.68% | 16.29% | 12.77% | 16.00% | 12.08% |
Effective Tax Rate | 25.84% | 25.33% | 11.79% | 10.54% | 24.52% | 41.76% |
Revenue as Reported | - | - | - | - | - | 10.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.